| Dr Heather S Abe, DO | |
|
12345 Sw Horizon Blvd Ste 57, Beaverton, OR 97007-9475 | |
| (503) 216-8820 | |
| Not Available |
| Full Name | Dr Heather S Abe |
|---|---|
| Gender | Female |
| Speciality | Obstetrics/gynecology |
| Experience | 15 Years |
| Location | 12345 Sw Horizon Blvd Ste 57, Beaverton, Oregon |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1265745947 | NPI | - | NPPES |
| 500654926 | Medicaid | OR |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207V00000X | Obstetrics & Gynecology | DO160676 (Oregon) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Providence Health And Services Oregon | 0648183608 | 1328 |
News Archive
A new public-private partnership between AstraZeneca and NIH's National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) will focus on supporting the work of the Drug-Induced Liver Injury Network (DILIN). DILIN is a group working to bring together essential scientific and financial resources to better understand drug-induce liver injury as well as effective screening, diagnostic and treatment options.
Researchers at the University of California, San Diego School of Medicine have found that the risk of patient harm increased two-fold in 2006 - the peak year that teaching hospitals nationwide embraced the pursuit of minimally invasive robotic surgery for prostate cancer. Results of the study are published in the July 2 online issue of JAMA Surgery.
The German Institute for Quality and Efficiency in Health Care already assessed the added benefit of ipilimumab in advanced melanoma in 2012. A considerable added benefit was found for patients who had already received previous treatment. In the new dossier compiled by the drug manufacturer, the drug was now compared with the appropriate comparator therapy dacarbazine specified by the Federal Joint Committee (G-BA) also for non-pretreated patients.
Researchers at the Joslin Diabetes Center have identified a gene that is responsible for the division and movement of marrow-derived, blood-forming stem cells, a finding that could have major implications for the future of bone marrow and blood cell transplantation.
For the first time, researchers have found a way to inject a precise dose of a gene therapy agent directly into a single living cell without a needle.
› Verified 5 days ago
| Entity Name | Providence Health & Services Oregon |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1023488343 PECOS PAC ID: 0648183608 Enrollment ID: O20031106000652 |
News Archive
A new public-private partnership between AstraZeneca and NIH's National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) will focus on supporting the work of the Drug-Induced Liver Injury Network (DILIN). DILIN is a group working to bring together essential scientific and financial resources to better understand drug-induce liver injury as well as effective screening, diagnostic and treatment options.
Researchers at the University of California, San Diego School of Medicine have found that the risk of patient harm increased two-fold in 2006 - the peak year that teaching hospitals nationwide embraced the pursuit of minimally invasive robotic surgery for prostate cancer. Results of the study are published in the July 2 online issue of JAMA Surgery.
The German Institute for Quality and Efficiency in Health Care already assessed the added benefit of ipilimumab in advanced melanoma in 2012. A considerable added benefit was found for patients who had already received previous treatment. In the new dossier compiled by the drug manufacturer, the drug was now compared with the appropriate comparator therapy dacarbazine specified by the Federal Joint Committee (G-BA) also for non-pretreated patients.
Researchers at the Joslin Diabetes Center have identified a gene that is responsible for the division and movement of marrow-derived, blood-forming stem cells, a finding that could have major implications for the future of bone marrow and blood cell transplantation.
For the first time, researchers have found a way to inject a precise dose of a gene therapy agent directly into a single living cell without a needle.
› Verified 5 days ago
| Entity Name | Providence Health & Services Oregon |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1003991845 PECOS PAC ID: 5395656284 Enrollment ID: O20031113000626 |
News Archive
A new public-private partnership between AstraZeneca and NIH's National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) will focus on supporting the work of the Drug-Induced Liver Injury Network (DILIN). DILIN is a group working to bring together essential scientific and financial resources to better understand drug-induce liver injury as well as effective screening, diagnostic and treatment options.
Researchers at the University of California, San Diego School of Medicine have found that the risk of patient harm increased two-fold in 2006 - the peak year that teaching hospitals nationwide embraced the pursuit of minimally invasive robotic surgery for prostate cancer. Results of the study are published in the July 2 online issue of JAMA Surgery.
The German Institute for Quality and Efficiency in Health Care already assessed the added benefit of ipilimumab in advanced melanoma in 2012. A considerable added benefit was found for patients who had already received previous treatment. In the new dossier compiled by the drug manufacturer, the drug was now compared with the appropriate comparator therapy dacarbazine specified by the Federal Joint Committee (G-BA) also for non-pretreated patients.
Researchers at the Joslin Diabetes Center have identified a gene that is responsible for the division and movement of marrow-derived, blood-forming stem cells, a finding that could have major implications for the future of bone marrow and blood cell transplantation.
For the first time, researchers have found a way to inject a precise dose of a gene therapy agent directly into a single living cell without a needle.
› Verified 5 days ago
| Entity Name | Providence Health & Services Oregon |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1114015971 PECOS PAC ID: 9335057447 Enrollment ID: O20031117000153 |
News Archive
A new public-private partnership between AstraZeneca and NIH's National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) will focus on supporting the work of the Drug-Induced Liver Injury Network (DILIN). DILIN is a group working to bring together essential scientific and financial resources to better understand drug-induce liver injury as well as effective screening, diagnostic and treatment options.
Researchers at the University of California, San Diego School of Medicine have found that the risk of patient harm increased two-fold in 2006 - the peak year that teaching hospitals nationwide embraced the pursuit of minimally invasive robotic surgery for prostate cancer. Results of the study are published in the July 2 online issue of JAMA Surgery.
The German Institute for Quality and Efficiency in Health Care already assessed the added benefit of ipilimumab in advanced melanoma in 2012. A considerable added benefit was found for patients who had already received previous treatment. In the new dossier compiled by the drug manufacturer, the drug was now compared with the appropriate comparator therapy dacarbazine specified by the Federal Joint Committee (G-BA) also for non-pretreated patients.
Researchers at the Joslin Diabetes Center have identified a gene that is responsible for the division and movement of marrow-derived, blood-forming stem cells, a finding that could have major implications for the future of bone marrow and blood cell transplantation.
For the first time, researchers have found a way to inject a precise dose of a gene therapy agent directly into a single living cell without a needle.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Heather S Abe, DO Po Box 3158, Portland, OR 97208-3158 Ph: (503) 215-6494 | Dr Heather S Abe, DO 12345 Sw Horizon Blvd Ste 57, Beaverton, OR 97007-9475 Ph: (503) 216-8820 |
News Archive
A new public-private partnership between AstraZeneca and NIH's National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) will focus on supporting the work of the Drug-Induced Liver Injury Network (DILIN). DILIN is a group working to bring together essential scientific and financial resources to better understand drug-induce liver injury as well as effective screening, diagnostic and treatment options.
Researchers at the University of California, San Diego School of Medicine have found that the risk of patient harm increased two-fold in 2006 - the peak year that teaching hospitals nationwide embraced the pursuit of minimally invasive robotic surgery for prostate cancer. Results of the study are published in the July 2 online issue of JAMA Surgery.
The German Institute for Quality and Efficiency in Health Care already assessed the added benefit of ipilimumab in advanced melanoma in 2012. A considerable added benefit was found for patients who had already received previous treatment. In the new dossier compiled by the drug manufacturer, the drug was now compared with the appropriate comparator therapy dacarbazine specified by the Federal Joint Committee (G-BA) also for non-pretreated patients.
Researchers at the Joslin Diabetes Center have identified a gene that is responsible for the division and movement of marrow-derived, blood-forming stem cells, a finding that could have major implications for the future of bone marrow and blood cell transplantation.
For the first time, researchers have found a way to inject a precise dose of a gene therapy agent directly into a single living cell without a needle.
› Verified 5 days ago
Sandra Meacham Reed, M.D. Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 4855 Sw Western Ave, Beaverton, OR 97005 Phone: 503-643-7565 | |
Dr. Virginia Sohn Kelly, M.D. Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 12345 Sw Horizon Blvd Ste 57, Beaverton, OR 97007 Phone: 503-216-8820 | |
Martin L Schwartz, M.D. Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 4855 Sw Western Ave, Beaverton, OR 97005 Phone: 503-643-7565 | |
Amy R Bruner, M.D. Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 1975 Nw 167th Pl Ste 100, Beaverton, OR 97006 Phone: 503-804-3861 Fax: 503-662-6541 | |
Nancy Ann Jauch, M.D. Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 4855 Sw Western Ave, Beaverton, OR 97005 Phone: 503-643-7565 | |
Kevin Scott Overbeck, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 4855 Sw Western Ave, Beaverton, OR 97005 Phone: 503-643-7565 |